Favipiravir exposure and pregnancy outcome of COVID-19 patients

Millions of people have died of COVID-19 since the pandemic began. During the past two years, many drug and vaccine studies have been conducted against the novel type of coronavirus. However, at the time of this writing, there are still serious questions about the prophylaxis and pharmacotherapy options, and unfortunately the deaths continue to climb.
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - Category: OBGYN Authors: Source Type: research